Showing results (161-170 of 184) with videos related to
Sort By:
Pageof 19
European Journal of Medicinal Chemistry|June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detectionAntonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.Molecular Therapy. Methods & Clinical Development|December 24, 2025
AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administrationMichal G Fortuna, Lyle H Nyberg, Naz Taskin, et al.European Journal of Medicinal Chemistry|October 17, 2017
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrierMaria Grazia Perrone, Paola Vitale, Savina Ferorelli, et al.European Journal of Medicinal Chemistry|July 16, 2017
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6)Gino Cingolani, Andrea Panella, Maria Grazia Perrone, et al.Clinical and Experimental Dermatology|February 24, 2018
Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from MexicoA H Saeidian, L Youssefian, M G Moreno Trevino, et al.Journal of the National Cancer Institute|October 6, 1993
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcomaJ M Pluda, L E Shay, A Foli, et al.European Journal of Human Genetics : EJHG|October 21, 2018
TBL1Y: a new gene involved in syndromic hearing lossMariateresa Di Stazio, Chiara Collesi, Diego Vozzi, et al.Radiology|August 28, 2019
A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic MetastasisCarin F Gonsalves, David J Eschelman, Robert D Adamo, et al.Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug DeliveryGiuseppe Cinà, Marina Massaro, Andrea Pappalardo, et al.European Journal of Medicinal Chemistry|July 2, 2013
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogensCosimo G Fortuna, Carmela Bonaccorso, Alessandra Bulbarelli, et al.Pageof 19